Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanjie Prescription is a traditional Chinese medicine (TCM) herbal formula used primarily in China. It is not a single pharmaceutical compound but rather a multi-herb prescription, with variations in composition depending on the specific clinical indication and practitioner. The formula is most commonly referenced for its use in treating phlegm stagnation syndromes such as hyperthyroidism and certain tumors or nodules. One documented version of the Xiaoying Sanjie prescription includes Bupleurum (10 g), Radix paeoniae alba (10 g), Fructus aurantii (10 g), Pinellia ternata (10 g), Ginger magnolia (6 g), Poria (15 g), Prunella vulgaris (10 g), Radix scrophulariae (10 g), Zhejiang Fritillaria (10 g), Forsythia suspensa fruit (10 g), Albizia flower (10 g), Salvia miltiorrhiza root and rhizome (10g), Perilla leaf (6g) and Licorice root and rhizome(5g)[6]. The mechanism of action is based on TCM theory—resolving phlegm, softening hard masses, dispersing nodules, clearing heat, detoxifying, promoting blood circulation and relieving depression[6]. There are also references to "Tangcancer-Sanjie" prescriptions being used adjunctively with targeted therapies for non-small cell lung cancer[8][10], though exact compositions may vary.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanjie Prescription.